Navigation Links
Taking Control of Diabetes: Support World Diabetes Day (14th November 2010)

Taking Control of Diabetes: Support World Diabetes Day (14th November 2010) -- LONDON, October 28, 2010 /PRNewswire/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Trade Show News Click to view news release full screen  

Taking Control of Diabetes: Support World Diabetes Day (14th November 2010)


LONDON, October 28, 2010 /PRNewswire/ -- Diabetic Hypoglycemia supports World Diabetes Day on the 14th November 2010 in raising the global awareness of diabetes (

The theme of World Diabetes Day in 2010 is "Let's take control of diabetes. Now", which marks the second year of the five-year focus on diabetes education and prevention, the theme selected by the International Diabetes Federation and the World Health Organization for World Diabetes Day 2009-2013. The focus of the campaign is to raise awareness of diabetes in the general public, those with diabetes and those at risk. Tools to improve knowledge of diabetes will be disseminated in an attempt to prevent diabetes and/or its complications. It is also a major aim of the campaign to inform governments and policy-makers of the cost-effective implications of diabetes prevention strategies and diabetes education.

In the latest issue of Diabetic Hypoglycemia, Dr Ana Maria Arbelaez and Dr Tamara Hershey from the Washington University School of Medicine, St Louis, USA discuss the effects of hypoglycemia on brain structure and function and how neuroimaging tools can be used to measure these effects over the short, intermediate and long-term. They also describe the areas of the brain thought classically to be particularly susceptible to damage from hypoglycemia, and how technologic advances in imaging techniques show that the brain regions thought to be particularly affected may not be correct. Professor Anthony McCall's related editorial details key points of interest in the feature article and points out the particular vulnerability of the developing brain to hypoglycemia.

About Diabetic Hypoglycemia

Published by ESP Bioscience (Crowthorne, UK), Diabetic Hypoglycemia is an influential online diabetes journal led by Editor-in-Chief Professor Brian Frier (Edinburgh, UK), with Associate Editors: Professor Simon Heller (Sheffield, UK), Professor Christopher Ryan (Pittsburgh, USA), Dr Rory McCrimmon (Dundee, UK), and Professor Anthony L. McCall (Virginia, USA). Published three times annually, Diabetic Hypoglycemia provides an interactive forum for the sharing of practical knowledge and opinions in the field of hypoglycemia.

To explore Diabetic Hypoglycemia, please take the guided tour:

Diabetic Hypoglycemia is published by ESP Bioscience, supported by an unrestricted educational grant from Novo Nordisk A/S (Bagsvaerd, Denmark).

Contact: Editorial Office E: T: +44-(0)1344-762531 F: +44-(0)203-0514753

SOURCE ESP Bioscience
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. WAVE Conference and Exhibition 2011 Taking Products to Market incorporating Micro & Nano Technology
2. Gloabl Harvest Initiative: Taking Down Fences To Meet Future Needs
3. Patton Medical Devices Partners With Unomedical to Develop and Market the i-port Advance(TM) Injection Port for People Taking Multiple Daily Injections
4. Diagnostic Imaging to Deliver Its 11th Annual Webcast of Key Events Taking Place at RSNA 2008
5. Miniaturizing memory: Taking data storage to the molecular level
6. Lotus Pharmaceuticals Announces New Patent for Controlled-Release Diabetes Drug
7. HumanTouch Expands Services to the Centers for Disease Control and Prevention as a Prime Contract Holder as Part of $1.0 Billion Contract
8. The perfect nanocube: Precise control of size, shape and composition
9. Marrone Bio Innovations to Present Invasive Mussel Control Solution
10. Powerful new way to control magnetism
11. Phase III Randomised Controlled Trial Confirms Clinical Efficacy and Safety of Radioembolisation Using 90Y-resin Microspheres for Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy
Post Your Comments:
(Date:11/27/2015)... November 27, 2015 ... popularity of companion diagnostics is one of ... market with pharmaceutical companies and diagnostic manufacturers ... tests. . --> ... report on global cancer biomarkers market spread ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and CEO of Neurocrine Biosciences, will be presenting ... New York . ... website approximately 5 minutes prior to the presentation to ... the presentation will be available on the website approximately ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
Breaking Biology Technology:
(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... , November 17, 2015 ... au 19 novembre  2015.  --> Paris ... --> DERMALOG, le leader de l,innovation biométrique, ... la fois passeports et empreintes sur la même surface ... les passeports et l,autre pour les empreintes digitales. Désormais, ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
Breaking Biology News(10 mins):